US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

158.16

+3.982.58%

Volume:7.39M

Turnover:1.17B

Market Cap:10.87B

PE:8.68

High:160.33

Open:157.08

Low:156.94

Close:154.18

52wk High:169.89

52wk Low:93.49

Shares:68.75M

Float Shares:68.75M

Volume Ratio:0.98

T/O Rate:10.74%

Dividend:0.57

Dividend Rate:0.36%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Fortis, IHH Update Markets as Tokyo Court Dismisses NTK Claim Against Daiichi Sankyo

Aurobindo Pharma to Engage Investors at Kotak Healthcare Forum 2026

RBC Capital Sticks to Its Buy Rating for Legend Biotech (LEGN)

IHH Healthcare Expected to Take Minimal Hit from Tokyo Court Ruling

Genscript Biotech to Raise HK$2.33 Billion via Discounted Share Placing for AIDD Expansion

New F&P Healthcare Bull Expects Growth, Reliable Delivery

National Healthcare Properties Completes Major Facility Portfolio Sale

Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)

Helus Pharma CEO to Spotlight Novel Mental Health Pipeline at Morgan Stanley Healthcare Conference

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Sector Update: Healthcare

MT Newswires Live

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)

Community Healthcare management to meet with Piper Sandler

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)

Oncolytics Biotech Reports Positive Pelareorep Preclinical Results

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoY

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/XBI/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":158.16,"timestamp":1789671477261,"preClose":154.18,"halted":0,"volume":7387048,"delay":0,"changeRate":0.025813983655467568,"floatShares":68750000,"shares":68750000,"eps":18.23,"marketStatus":"Trading","change":3.98,"latestTime":"09-17 14:58:04 EDT","open":157.08,"high":160.33,"low":156.94,"amount":1171851524.91656,"amplitude":0.021987,"askPrice":158.16,"askSize":49,"bidPrice":158.13,"bidSize":95,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.18,"sharesOutstanding":63325000,"nav":154.028797,"aum":10385391642.43,"dividendRate":0.003603,"bidAskSpread":0.000229,"preHourTrading":{"tag":"盘前","latestPrice":157.16,"preClose":154.18,"latestTime":"09:28 EDT","volume":17657,"amount":2755328.05895,"timestamp":1789651727445,"change":2.98,"changeRate":0.019328,"amplitude":0.014853},"postHourTrading":{"tag":"盘后","latestPrice":154.5,"preClose":154.18,"latestTime":"19:53 EDT","volume":37711,"amount":5808520.5381,"timestamp":1789602836010,"change":0.32,"changeRate":0.002075,"amplitude":0.004216},"volumeRatio":0.984751,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1792123200000,"strike":"153.0","timestamp":1789657293125,"price":2.8,"volume":4000,"amount":1120000,"type":"-"}]},"impliedVol":0.3086,"impliedVolPercentile":0.4701},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":68750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.984751,"shares":68750000,"dividePrice":0.5699,"high":160.33,"amplitude":0.021987,"preClose":154.18,"low":156.94,"week52Low":93.49,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":158.16,"committee":0.319444,"eps":18.23,"divideRate":0.003603,"volume":7387048,"delay":0,"ttmEps":18.23,"open":157.08,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":156.82,"twentyDayClose":169.55,"sixtyDayClose":147.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666423155","title":"Fortis, IHH Update Markets as Tokyo Court Dismisses NTK Claim Against Daiichi Sankyo","url":"https://stock-news.laohu8.com/highlight/detail?id=2666423155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666423155?lang=en_us&edition=fundamental","pubTime":"2026-09-11 15:55","pubTimestamp":1789113332,"startTime":"0","endTime":"0","summary":"An announcement from Fortis Healthcare Ltd. ( ($IN:FORTIS) ) is now available. Fortis Healthcare has updated Indian exchanges on a key legal matter...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fortis-ihh-update-markets-as-tokyo-court-dismisses-ntk-claim-against-daiichi-sankyo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fortis-ihh-update-markets-as-tokyo-court-dismisses-ntk-claim-against-daiichi-sankyo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","XBI","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666423385","title":"Aurobindo Pharma to Engage Investors at Kotak Healthcare Forum 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666423385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666423385?lang=en_us&edition=fundamental","pubTime":"2026-09-11 15:54","pubTimestamp":1789113264,"startTime":"0","endTime":"0","summary":"The latest update is out from Aurobindo Pharma Ltd ( ($IN:AUROPHARMA) ). Aurobindo Pharma Limited has notified the stock exchanges that its officia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurobindo-pharma-to-engage-investors-at-kotak-healthcare-forum-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurobindo-pharma-to-engage-investors-at-kotak-healthcare-forum-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KCE","BK4581","XBI","BK4588","BK4211","BK4137","ISBC","LU0128526141.USD","XLV","BK4585","LABU","HCSG","LU0029874061.USD","FET","BK4179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517968","title":"RBC Capital Sticks to Its Buy Rating for Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517968","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517968?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:45","pubTimestamp":1789091122,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on Legend Biotech on September 9 and set a price target of $58.00. The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666512498","title":"IHH Healthcare Expected to Take Minimal Hit from Tokyo Court Ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2666512498","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666512498?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:20","pubTimestamp":1789089600,"startTime":"0","endTime":"0","summary":"0120 GMT - IHH Healthcare is likely to face minimal operational and financial impact from an unfavorable Tokyo court ruling for its unit Northern TK Venture, says Citi analyst Megat Fais in a note. The unit was ordered to bear litigation costs after the court dismissed its claims against Daiichi Sankyo. NTK filed the lawsuit in October 2023 alleging that it suffered damages, including suspension of a tender offer due to the interference of Daiichi Sankyo. Legal expenses, even of several million ringgit, would be small relative to IHH's more than 2 billion ringgit profit base, Fais says. Investors may remain focused on IHH's volume growth, margins, capacity expansion and earnings prospects across core markets, he adds. Citi has a buy rating and target price of 10.40 ringgit on IHH. Shares are unchanged at 7.89 ringgit.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","LU0029874061.USD","XBI","DSNKY","BK4581","LABU","LU0128526141.USD","XLV","BK6092","BK6511","Q0F.SI","HCSG","BK4137","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666174511","title":"Genscript Biotech to Raise HK$2.33 Billion via Discounted Share Placing for AIDD Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2666174511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666174511?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:38","pubTimestamp":1789083520,"startTime":"0","endTime":"0","summary":"Genscript Biotech ( ($HK:1548) ) has provided an announcement. Genscript Biotech has entered into a placing agreement to issue 77,126,000 new share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genscript-biotech-to-raise-hk2-33-billion-via-discounted-share-placing-for-aidd-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genscript-biotech-to-raise-hk2-33-billion-via-discounted-share-placing-for-aidd-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666511533","title":"New F&P Healthcare Bull Expects Growth, Reliable Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2666511533","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666511533?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:30","pubTimestamp":1789083000,"startTime":"0","endTime":"0","summary":"2330 GMT - Fisher & Paykel Healthcare gains a bull in Citi, which thinks it offers investors both growth and reliable delivery. Citi expects \"sustainable double-digit earnings growth in the midterm and lower exposure to consumer dynamics\" from the medical-device maker than other healthcare stocks across Australia and New Zealand. It upgrades the stock to \"buy\" from \"neutral.\" It raises its price target to NZ$51.00/share from NZ$40.00/share previously. The stock is down 1.3%, at NZ$43.37.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","XBI","XLV","LU0128526141.USD","BK4585","BK4137","BK4581","LABU","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666427516","title":"National Healthcare Properties Completes Major Facility Portfolio Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2666427516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666427516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:05","pubTimestamp":1789074317,"startTime":"0","endTime":"0","summary":"National Healthcare Properties ( ($HLTC) ) just unveiled an update. On September 10, 2026, National Healthcare Properties completed the first tranc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/national-healthcare-properties-completes-major-facility-portfolio-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/national-healthcare-properties-completes-major-facility-portfolio-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","NHP","XBI","BK4225","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516920","title":"Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516920?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:05","pubTimestamp":1789074300,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into defensive sectors.Medical-device maker Boston Scientific has restored its manufacturing, order fulfillment and shipping operations after a disruption by last month's cyberattack.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","BK4581","BK4588","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666163445","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666163445","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666163445?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:50","pubTimestamp":1789073400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0208 ET - CSPC Pharmaceutical's coming clinical data presentatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666895518","title":"Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666895518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666895518?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:40","pubTimestamp":1789065605,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eocene (EOCN) and Dyne Therapeutics (DYN). Eocene (EOCN) Maxim Gr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4505","LU0128526141.USD","BK4585","HCSG","DYN","BK4588","BK4137","BK4139","XBI","LU0029874061.USD","LABU","EOCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518845","title":"Helus Pharma CEO to Spotlight Novel Mental Health Pipeline at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518845","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666518845?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:27","pubTimestamp":1789064836,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Helus Pharma ( ($HELP) ). Helus Pharma, operating under the Cybin Inc. banner, is a clinical-stage mental healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/helus-pharma-ceo-to-spotlight-novel-mental-health-pipeline-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/helus-pharma-ceo-to-spotlight-novel-mental-health-pipeline-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","BK4137","BK4581","BK4585","LU0128526141.USD","LABU","XLV","HCSG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559053","title":"Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559053?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:51","pubTimestamp":1789062660,"startTime":"0","endTime":"0","summary":"Ninety percent of the expensive, widely used biologic drugs facing patent expiration by 2034 have no lower-cost alternatives in development, according to a new report by the Association for Accessible","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","IHE","BK4137","LU0128526141.USD","XLV","BK4585","LABU","HCSG","LU0029874061.USD","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666979055","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666979055","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666979055?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:10","pubTimestamp":1789060238,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index shedding 0.2% and the State Street Health Care Select Sector SPDR ETF  down 0.4%.The iShares Biotechnology ETF  dropped 1.3%.In corporate news, Cooper  shares fell past 14% after the company cut its fiscal 2026 guidance. Separately, BofA Securities downgraded Cooper to neutral from buy and lowered its price target to $65 from $80. BofA said Cooper could not sell CooperSurgical at an attractive valuation given competition from the Paragard intrauterine device and the fertility litigation settlement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","BK4581","LABU","LU0128526141.USD","LU1992135399.USD","BK4588","XLV","BK7016","COO","IBB","BK4585","COO.AU","LU1992135472.HKD","HCSG","GB00BDT5M118.USD","LU2211815571.USD","LU2272731600.USD","LU0029874061.USD","XBI","BK4198","LU2272731782.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666927165","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666927165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666927165?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:20","pubTimestamp":1789057200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0208 ET - CSPC Pharmaceutical's coming clinical data presentatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4581","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910045","title":"Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910045?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:40","pubTimestamp":1789051210,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fortrea Holdings Inc. (FTRE) and Immunome (IMNM). ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4121","XBI","XLV","LABU","BK4581","BK4137","BK4585","IMNM","HCSG","FTRE","BK4588","LU0029874061.USD","BK4139","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599760","title":"Community Healthcare management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599760","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599760?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:55","pubTimestamp":1789048524,"startTime":"0","endTime":"0","summary":"Meeting to be held on September 17 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/community-healthcare-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/community-healthcare-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4585","KBWY","XBI","BK4588","BK4225","CHCT","LABU","BK4203"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666996625","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666996625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666996625?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","ZYME","LABU","XLV","LU0029874061.USD","BK4007","BK4568","LU0128526141.USD","AXSM","BK4588","BK4563","BK4505","PTH","LU2324357040.USD","OCGN","XBI","BK4139","HCSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666259636","title":"Oncolytics Biotech Reports Positive Pelareorep Preclinical Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2666259636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666259636?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:48","pubTimestamp":1789044494,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Oncolytics Biotech ( ($ONCY) ). On September 10, 2026, Oncolytics Biotech announced positive preclinical result...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncolytics-biotech-reports-positive-pelareorep-preclinical-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncolytics-biotech-reports-positive-pelareorep-preclinical-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666934115","title":"Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666934115","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666934115?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:15","pubTimestamp":1789042500,"startTime":"0","endTime":"0","summary":"Preclinical results demonstrate pelareorep activity is maintained in the presence of RAS inhibition Findings support further evaluation of pelareorep’s potential to deepen and prolong responses to RAS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359477/0/en/oncolytics-biotech-announces-positive-preclinical-results-combining-pelareorep-with-a-pan-ras-inhibitor-in-colorectal-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666843598","title":"Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2666843598","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666843598?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:30","pubTimestamp":1789039840,"startTime":"0","endTime":"0","summary":"Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 100 percent decrease over losses of $(0.10) per share from the same period last year.  The company reported $19.862 million in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61708920/burning-rock-biotech-q2-eps-0-20-down-0-10-yoy-sales-19-862m-down-20-737m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":8,"totalSize":332,"code":"91000000","status":"200"}]}}